SystImmune
Redmond, Washington, United States · Biopharma, Biotechnology, Pharmaceutical · 50 employees
Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug conjugates (ADC's). Our objective is to create biologics that work through systematic intervention on the solid tumor micro-environment, to either directly attack the tumor
Funding history
- Funding Round — $7.9M — Oct 2024
- Funding Round — $7.2M — Jun 2024
Recent signals
- Oct 18, 2024: Raised $7.9M
- Jun 04, 2024: Raised $7.2M
- May 23, 2024: SystImmune Appoints Dr. Jonathan Cheng as Chief Medical Officer
- Apr 22, 2024: SystImmune Appoints Jie D'Elia, Ph.D., MBA, as Chief Executive Officer
See plans & pricing → Track SystImmune’s funding, hiring, and signals — with verified contacts — on Fundz.